Is it appropriate to study blood ghrelin and obestatin in non-alcoholic fatty liver disease (NAFLD) without using protease inhibitors?

Annals of Hepatology

Volumn 11, Issue 1, 2012, Pages 145-146

  Aydin, Suleyman ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; GAMMA GLUTAMYLTRANSFERASE; GHRELIN; OBESTATIN; PROTEINASE; PROTEINASE INHIBITOR;

ACYLATION; DISEASE SEVERITY; HUMAN; INFLAMMATION; LETTER; NONALCOHOLIC FATTY LIVER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE;

EID: 83055197018     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31501-7     Document Type: Letter

References (8)

1. Gutierrez-Grobe Y, Villalobos-Blasquez I, Sánchez-Lara K, Villa AR, Ponciano-Rodríguez G, Ramos MH, Chavez-Tapia NC, Uribe M, Méndez-Sánchez N. High ghrelin and obestatin levels and low risk of developing fatty liver. Ann Hepatol 2010; 9: 52-7.
2. Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E, Enomoto M, Ono F, Kangawa K. Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin Chem 2004; 50: 1077-108.
3. Blatnik M, Soderstrom CI. A practical guide for the stabilization of acylghrelin in human blood collections. Clin Endocrinol 2011; 74: 325-31.
4. Available from: http://www.phoenixpeptide.com.
5. Available from: http://www.bioquote.com.
6. Aydin S, Sahin I, Demirel U, Aksoy A. To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease? Metabolism 2011; 60: 1.
7. Aydin S. Discovery of ghrelin hormone: research and clinical applications. Turk J Biochem 2007; 32: 76-89.
8. Rawlings ND, Barrett AJ, Bateman A. MEROPS: the peptidase database. Nucleic Acids Res 2010; 38: 227-33.